Schildge J, Klar B, Weinstock N
Abt. Pneumologie, St. Vincentius-Krankenhäuser Karlsruhe.
Pneumologie. 2000 Sep;54(9):385-91. doi: 10.1055/s-2000-7183.
As a result of several studies with different animal models there is evidence that the concentration of AP in BAL is produced in the pneumocyte II and that an increase of AP in the BAL is a marker of tissue damage. By measuring AP in the BAL of patients with interstitial lung diseases we investigated its potential role as a diagnostic tool. To detect plasma leakage we also measured the concentration of albumin in the BAL. We studied 85 patients with following diagnoses: Sarcoidosis in 34 patients (Stage 1/2/3 14/7/13), idiopathic pulmonary fibrosis (IPF) in 14, bronchiolitis obliterans with organizing pneumonia (BOOP) in 7, hypersensitivity pneumonitis (HP) in 6. The control group consisted in 24 patients (13 nonsmokers, 11 smokers). In IPF and BOOP we observed significantly higher concentrations of AP than in controls and sarcoidosis (42.4 +/- 36.6 and 35.6 +/- 16 vs. 15.8 +/- 12.7 and 15.0 +/- 9.8 U/l, p < 0.05, ANOVA). Compared with controls in sarcoidosis higher concentrations of albumin (5.7 +/- 4 vs. 13.2 +/- 10 mg/dl, p < 0.05, ANOVA) and a lower AP/albumin-ratio (3.6 +/- 3.0 vs. 1.3 +/- 0.9 U/10 mg, p < 0.05, ANOVA) were seen. This result is an argument against plasma leakage as the source of AP in BAL. There were no differences in AP and albumin between the different stages of sarcoidosis and between smokers and nonsmokers in the control group. We conclude, that there are different concentrations of AP and albumin in BAL in different interstitial lung diseases. Compared with controls we observed higher concentrations of AP and an AP/albumin-ratio in the normal range in IPF, a normal concentration of AP and a lowered AP/albumin-ratio in sarcoidosis.
多项针对不同动物模型的研究结果表明,支气管肺泡灌洗(BAL)中表面活性物质相关蛋白(AP)的浓度是由Ⅱ型肺细胞产生的,且BAL中AP的增加是组织损伤的一个标志。通过测量间质性肺疾病患者BAL中的AP,我们研究了其作为诊断工具的潜在作用。为检测血浆渗漏,我们还测量了BAL中白蛋白的浓度。我们研究了85例诊断如下的患者:34例结节病患者(1/2/3期分别为14/7/13例),14例特发性肺纤维化(IPF)患者,7例闭塞性细支气管炎伴机化性肺炎(BOOP)患者,6例过敏性肺炎(HP)患者。对照组包括24例患者(13例不吸烟者,11例吸烟者)。在IPF和BOOP患者中,我们观察到AP浓度显著高于对照组和结节病患者(分别为42.4±36.6和35.6±16与15.8±12.7和15.0±9.8 U/L,p<0.05,方差分析)。与对照组相比,结节病患者的白蛋白浓度更高(5.7±4与13.2±10 mg/dl,p<0.05,方差分析),而AP/白蛋白比值更低(3.6±3.0与1.3±0.9 U/10 mg,p<0.05,方差分析)。这一结果表明,血浆渗漏并非BAL中AP的来源。结节病不同阶段之间以及对照组中吸烟者和不吸烟者之间的AP和白蛋白水平并无差异。我们得出结论,不同间质性肺疾病患者BAL中的AP和白蛋白浓度不同。与对照组相比,我们观察到IPF患者的AP浓度较高且AP/白蛋白比值在正常范围内,结节病患者的AP浓度正常但AP/白蛋白比值降低。